Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trialLudwig Kappos, Paul D. Crowe, Massimo Filippi et al.|Nature Medicine|2000Cited by 515
Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis.Tatiana Koudriavtseva, Carlo Pozzilli, Alan J. Thompson et al.|Journal of Neurology Neurosurgery & Psychiatry|1997Cited by 95